KBI Biopharma · 1 month ago
Senior Director, Business Development, Global Pharma Accounts (East Coast)
Crown Bioscience is a company focused on providing innovative solutions in the field of translational science. They are seeking a Senior Director of Business Development to develop and execute tailored sales strategies for the Top 25 Global Pharma accounts, specifically in the area of oncology.
BiopharmaBiotechnologyHealth CareManufacturing
Responsibilities
Develop and implement strategic sales plans (short term and long term) to achieve corporate goals in the assigned market
Identify and analyze business opportunity, and formulate plans to capture the opportunity and deal with problems
Contact prospective customer/partner companies to further explore business opportunities and manage negotiations
Develop and maintain key business relationships across a broad sphere of influence, both internally and externally
Logistics management in daily order
Flexibility spending up to 40% travel when needed
Qualification
Required
Bachelor Degree in Molecular and Cell Biology or related life science field
Drug discovery experience selling to Top 25 Global Pharma – at least 5 years of experience
Relevant business development experience (pharmaceutical, biotech, CRO) is required and proven track record of achieving sales targets
Masterful selling skills and strategic mindset, that result in strong and trusting customer relationships
Preferred
Advanced degree (Master's/PhD) preferred; equivalent experience in sales will also be considered
Have strong background in oncology and in vivo pharmacology preferred with at least 8 years in a business development or sales role
Have a proven track record of selling to Global Top25 Pharma and ability to win complex deals and manage negotiations at all levels, achieving long term value is highly desired
Company
KBI Biopharma
KBI Biopharma, Inc. (KBI) is a leading development and contract manufacturing organization serving the biopharmaceutical industry. We help
Funding
Current Stage
Late StageTotal Funding
$109.47MKey Investors
JSR
2025-10-01Corporate Round· $99.87M
2016-12-08Series Unknown
2009-09-22Series Unknown· $9.6M
Recent News
Kalaris Therapeutics, Inc.
2025-11-14
Company data provided by crunchbase